Datasets:
jarrydmartinx
/
support2

Dataset card Data Studio Files
xet
Community
age
float64
18
102
sex
stringclasses
2 values
hospdead
int64
0
1
slos
int64
3
343
dzgroup
stringclasses
8 values
dzclass
stringclasses
4 values
num.co
int64
0
9
edu
float64
0
31
⌀
income
stringclasses
4 values
scoma
float64
0
100
⌀
charges
float64
1.17k
1.44M
⌀
totcst
float64
0
633k
⌀
totmcst
float64
-102.72
711k
⌀
avtisst
float64
1
83
⌀
race
stringclasses
5 values
sps
float64
0.2
99.2
⌀
aps
float64
0
143
⌀
surv2m
float64
0
0.97
⌀
surv6m
float64
0
0.95
⌀
hday
int64
1
148
diabetes
int64
0
1
dementia
int64
0
1
ca
stringclasses
3 values
prg2m
float64
0
1
⌀
prg6m
float64
0
1
⌀
dnr
stringclasses
3 values
dnrday
float64
-88
285
⌀
meanbp
float64
0
195
⌀
wblc
float64
0
200
⌀
hrt
float64
0
300
⌀
resp
float64
0
90
⌀
temp
float64
31.7
41.7
⌀
pafi
float64
12
890
⌀
alb
float64
0.4
29
⌀
bili
float64
0.1
63
⌀
crea
float64
0.1
21.5
⌀
sod
float64
110
181
⌀
ph
float64
6.83
7.77
⌀
glucose
float64
0
1.09k
⌀
bun
float64
1
300
⌀
urine
float64
0
9k
⌀
adlp
float64
0
7
⌀
adls
float64
0
7
⌀
sfdm2
stringclasses
5 values
adlsc
float64
0
7.07
event_times
int64
3
2.03k
event_indicators
int64
0
1
68.27399
male
0
15
ARF/MOSF w/Sepsis
ARF/MOSF
1
3
$11-$25k
0
51,694
31,447.4531
29,663
26.666656
white
18.597656
35
0.862915
0.814941
1
0
0
no
0.8
0.7
no dnr
15
75
null
100
21
36.19531
null
null
0.5
1.299805
141
null
91
9
4,575
null
0
no(M2 and SIP pres)
0
977
0
68.89294
male
1
22
COPD
COPD/CHF/Cirrhosis
3
4
under $11k
0
43,100
27,005.6719
26,722
17.666656
black
23.199219
22
0.805908
0.68689
1
0
0
no
0.6
0.5
dnr after sadm
18
57
11.398438
150
10
39.89844
102
null
2.099609
0.799927
136
7.349609
101
18
2,080
null
1
<2 mo. follow-up
1
22
1
66.92694
female
0
6
Lung Cancer
Cancer
2
14
null
0
8,787
4,992.8555
3,342
11
white
18
12
0.68396
0.389954
1
0
0
metastatic
0.6
0.2
no dnr
6
69
1.099854
106
26
35.89844
472
2.5
1.5
1.199951
127
7.399414
196
10
1,680
3
2
null
2
104
1
79.23297
female
0
14
COPD
COPD/CHF/Cirrhosis
2
7
under $11k
0
150,446
95,675.0625
81,663
18
white
26.199219
22
0.562988
0.366943
35
0
0
no
0.5
0.4
no dnr
14
103
14.699219
128
42
36.69531
364
1.899902
6.399414
2.199707
147
7.389648
113
43
1,670
null
0
SIP>=30
0
865
1
44.82999
female
1
4
Cirrhosis
COPD/CHF/Cirrhosis
3
14
under $11k
100
4,454
null
null
12
white
46.296875
96
0.004999
0
1
0
0
no
null
null
dnr after sadm
2
103
15
114
24
33.79688
256.5
2.099609
9.798828
1
141
7.40918
113
14
1,575
null
null
<2 mo. follow-up
3.859863
4
1
66.71295
male
1
6
ARF/MOSF w/Sepsis
ARF/MOSF
2
14
under $11k
0
130,396
84,253.5625
71,807
45
white
38
69
0.375977
0.257996
23
0
0
no
0.2
0.1
dnr after sadm
2
100
14.699219
118
24
36.69531
276.625
null
null
1.099854
135
7.469727
107
18
1,445
null
0
<2 mo. follow-up
0
6
1
70.92694
female
1
9
MOSF w/Malig
ARF/MOSF
1
16
$25-$50k
0
113,333
69,972.8125
73,117
54
white
46
86
0.039993
0.011999
32
0
0
yes
0.3
0.3
no dnr
9
74
4.099609
74
10
36.59375
290.4375
null
null
0.899902
135
7.40918
210
22
2,090
null
0
<2 mo. follow-up
0
9
1
64.07397
male
1
15
ARF/MOSF w/Sepsis
ARF/MOSF
2
null
null
9
78,530
48,207.4375
43,088
37.333313
black
24.199219
58
0.756958
0.679932
3
1
0
no
null
null
dnr after sadm
15
77
16.097656
100
30
35.09375
90
null
null
1.5
146
7.229492
430
27
null
null
null
<2 mo. follow-up
2.287598
15
1
63.948
male
0
12
CHF
COPD/CHF/Cirrhosis
1
null
$11-$25k
0
22,745
13,961.0625
13,437
28.5
black
26.898438
36
0.774902
0.641968
1
0
0
no
0.6
0.6
no dnr
12
66
32.695313
64
29
35.79688
134
2
null
1.599854
132
7.399414
110
21
380
0
0
no(M2 and SIP pres)
0
973
0
66.47498
female
0
7
CHF
COPD/CHF/Cirrhosis
3
13
$11-$25k
0
5,886
4,096.3672
3,634
10.5
black
20.898438
27
0.846924
0.748901
1
1
0
no
null
null
no dnr
7
65
16.699219
104
40
36.5
200
2.399902
22.5
1.199951
139
7.459961
199
38
4,450
1
null
no(M2 and SIP pres)
1.166748
972
0
54.92398
male
1
6
Coma
Coma
2
null
null
100
25,869
19,248.6094
14,186
16
null
20.699219
38
0.32196
0.250977
6
0
0
no
null
null
dnr after sadm
1
67
4.5
100
22
36
null
null
0.399963
1
139
null
98
19
1,500
null
null
<2 mo. follow-up
2.609375
6
1
57.91397
female
0
5
Lung Cancer
Cancer
1
12
>$50k
0
7,104
null
null
8
white
22
25
0.616943
0.302979
1
0
0
metastatic
0.5
0.2
no dnr
5
71
13.5
73
25
36.69531
155
null
0.699951
7.099609
148
7.40918
200
57
1,960
5
4
<2 mo. follow-up
4
17
1
30.84698
female
0
66
ARF/MOSF w/Sepsis
ARF/MOSF
2
11
null
100
95,845
64,135.25
69,807
16.75
black
22.097656
20
0.671997
0.575928
1
0
0
no
0.9
0.95
no dnr
66
65
14.798828
50
12
36.89844
152.5
2.099609
0.799927
0.799927
136
7.459961
108
18
780
null
null
null
3.235352
896
1
36.92499
female
1
28
ARF/MOSF w/Sepsis
ARF/MOSF
0
14
$11-$25k
0
151,066
95,726.5
83,119
33.25
white
30
45
0.815918
0.754883
1
0
0
no
0.6
0.6
dnr after sadm
14
129
11.398438
56
45
39.39844
284
null
null
0.899902
144
7.459961
243
12
2,110
null
0
<2 mo. follow-up
0
28
1
44.32898
male
0
5
CHF
COPD/CHF/Cirrhosis
3
8
$25-$50k
0
null
null
null
11
white
21.597656
22
0.897949
0.829956
1
1
0
no
0.8
0.7
null
null
83
null
70
12
36.29688
null
null
null
null
140
null
282
null
3,800
0
null
no(M2 and SIP pres)
0.494751
864
1
47.37299
female
1
24
Cirrhosis
COPD/CHF/Cirrhosis
3
16
null
0
101,234
67,325.0625
57,193
40.333313
black
55.59375
82
0.054993
0.006
1
0
0
no
0.5
0.5
dnr after sadm
20
97
28.796875
106
46
38
151
2.399902
1.5
1.299805
136
7.449219
87
17
2,950
null
1
<2 mo. follow-up
1
24
1
67.53699
male
0
8
CHF
COPD/CHF/Cirrhosis
2
null
under $11k
0
16,884
10,548.1094
9,162
17
black
17.597656
20
0.868896
0.782959
2
0
0
no
0.5
0.5
no dnr
8
100
6
84
24
36.29688
176.1875
null
0.699951
0.699951
140
7.339844
115
18
3,025
null
4
<2 mo. follow-up
4
54
1
59.76199
male
0
6
Lung Cancer
Cancer
1
6
$11-$25k
0
13,286
6,966.7109
5,383
15
black
15.298828
22
0.751953
0.493958
1
0
0
metastatic
0.5
0.25
no dnr
6
77
7.099609
80
20
36.09375
null
3.699707
0.5
0.799927
139
null
157
12
2,650
2
2
SIP>=30
2
136
1
67.55096
male
1
3
MOSF w/Malig
ARF/MOSF
1
null
null
37
49,159
30,353.2031
25,562
31
null
59.195313
98
0
0
12
0
0
yes
null
null
no dnr
3
53
8.898438
110
23
36
197.9375
null
null
3.099609
129
7.339844
108
103
380
null
null
<2 mo. follow-up
1.974365
3
1
77.659
male
0
61
ARF/MOSF w/Sepsis
ARF/MOSF
1
12
under $11k
9
219,246
146,584.75
144,700
40.75
white
28
44
0.612915
0.506958
3
0
0
no
null
null
no dnr
61
115
9.5
70
23
36.09375
null
3.699707
0.799927
1.199951
142
null
112
7
4,600
null
0
adl>=4 (>=5 if sur)
0
162
1
72.42395
male
0
21
ARF/MOSF w/Sepsis
ARF/MOSF
2
null
null
0
30,845
20,463.3125
20,964
19.666656
white
24
42
0.781982
0.710938
1
0
0
no
0.85
0.75
no dnr
21
65
20.398438
136
12
39.59375
208
1.899902
0.399963
0.899902
135
7.40918
72
7
2,010
null
null
null
2.82666
656
1
37.71698
female
1
27
ARF/MOSF w/Sepsis
ARF/MOSF
1
12
under $11k
0
123,504
83,198.125
66,476
42.25
white
35
64
0.733887
0.651978
1
0
0
no
0.25
0.25
dnr after sadm
10
55
12.199219
74
38
35.5
290
null
null
5.799805
139
7.40918
218
120
110
null
6
<2 mo. follow-up
6
27
1
73.22699
female
0
113
Coma
Coma
0
2
null
55
173,742
123,581.25
124,106
28
white
22.5
18
0.396973
0.322998
1
0
0
no
null
null
dnr after sadm
38
121
8.298828
124
32
36.09375
162.5
null
1.5
0.699951
145
7.519531
179
35
1,755
null
1
adl>=4 (>=5 if sur)
1
173
1
56.05698
female
1
3
ARF/MOSF w/Sepsis
ARF/MOSF
4
15
$11-$25k
61
44,639
29,698.5469
29,694
12
black
77.890625
94
0
0
22
1
0
no
0.1
0.1
dnr after sadm
2
0
15.798828
0
0
35.5
232.5
null
null
2
153
7.449219
378
26
5,635
null
3
<2 mo. follow-up
3
3
1
63.84698
male
1
3
ARF/MOSF w/Sepsis
ARF/MOSF
2
20
>$50k
100
39,993
25,133.3281
23,895
3
white
31.796875
48
0.132996
0.060997
5
1
0
no
null
null
dnr after sadm
2
73
14.699219
130
32
36.19531
300
2.599609
1.099854
2
141
7.439453
150
28
443
null
null
<2 mo. follow-up
3.532715
3
1
68.73895
male
0
12
COPD
COPD/CHF/Cirrhosis
1
null
null
0
11,075
7,144.2578
8,268
11
other
17.898438
15
0.869995
0.783936
1
0
0
no
0.9
0.8
dnr after sadm
10
156
14.599609
124
32
38.19531
208.5625
null
null
0.899902
146
7.439453
297
47
2,010
null
null
null
2.753418
965
0
67.35095
female
0
7
Lung Cancer
Cancer
1
11
$25-$50k
0
12,901
7,968.5469
7,785
3.5
white
20.597656
19
0.623901
0.310974
1
0
0
metastatic
0.9
0.75
no dnr
7
69
14.398438
114
36
36.29688
87.75
null
null
1
138
7.429688
160
23
3,050
4
3
null
3
69
1
43.047
female
1
5
MOSF w/Malig
ARF/MOSF
1
16
$25-$50k
0
20,626
15,471.5938
11,961
48
white
29.597656
28
0.527954
0.411987
1
0
0
metastatic
0.2
0.1
dnr after sadm
3
59
17
116
16
38.79688
145.4375
2.899902
0.699951
1.099854
137
7.479492
128
19
1,250
null
null
<2 mo. follow-up
2.361328
5
1
50.71597
male
0
5
Colon Cancer
Cancer
1
14
null
0
5,168
3,181.8672
3,450
13
black
7.799805
29
0.921997
0.816895
1
0
0
metastatic
null
null
no dnr
5
69
16.097656
70
14
38.19531
212.5
1.699951
1.699951
1.699951
142
7.419922
199
53
3,865
1
1
no(M2 and SIP pres)
1
297
1
58.448
female
1
9
MOSF w/Malig
ARF/MOSF
1
16
>$50k
0
53,336
33,709.875
27,935
43.5
white
33.296875
47
0.449951
0.329956
2
0
0
yes
0.3
0.2
dnr after sadm
9
82
10
72
20
37
null
4.199219
0.399963
0.899902
141
null
96
12
null
4
5
<2 mo. follow-up
5
9
1
36.62097
female
1
8
ARF/MOSF w/Sepsis
ARF/MOSF
2
12
$25-$50k
37
40,649
26,247.6094
23,098
42
white
42.5
81
0.390991
0.271973
1
0
0
no
0.5
0.5
dnr after sadm
7
69
19.898438
66
20
37.39844
148.96875
2.699707
null
3.899902
130
7.5
237
62
2,970
null
0
<2 mo. follow-up
0
8
1
41.92697
female
1
8
ARF/MOSF w/Sepsis
ARF/MOSF
0
12
$25-$50k
44
206,256
138,603.875
142,798
47.5
white
22.597656
41
0.721924
0.635986
22
0
0
no
0.75
0.7
dnr after sadm
7
113
7.699219
74
22
33.79688
230.59375
1.899902
0.699951
1.099854
135
7.329102
290
15
2,240
null
0
<2 mo. follow-up
0
8
1
24.101
female
0
10
ARF/MOSF w/Sepsis
ARF/MOSF
0
12
null
0
10,079
6,416.2148
6,694
12.5
white
20.699219
36
0.927979
0.901978
1
0
0
no
1
0.75
no dnr
10
49
13
60
6
36.79688
265
2.399902
1.599854
2
150
7.369141
100
66
1,490
2
3
adl>=4 (>=5 if sur)
3
958
0
76.97198
male
0
8
CHF
COPD/CHF/Cirrhosis
4
null
$11-$25k
0
17,070
10,639.7812
10,958
11.5
white
20.796875
34
0.813965
0.697998
1
1
0
no
0.8
0.75
no dnr
8
73
8.5
46
16
35.79688
152.375
null
1.099854
1.799805
144
7.429688
88
29
1,000
0
0
no(M2 and SIP pres)
0
608
1
68.62994
male
0
69
ARF/MOSF w/Sepsis
ARF/MOSF
1
null
null
37
134,910
null
null
22.75
black
18.597656
24
0.720947
0.634888
8
0
0
no
0.5
0.3
no dnr
69
39
1
144
28
38.89844
160
2.299805
2.199707
5
143
7.219727
70
68
975
null
0
adl>=4 (>=5 if sur)
0
960
0
50.23099
male
0
44
MOSF w/Malig
ARF/MOSF
1
12
null
0
151,085
98,833.75
96,276
27.25
white
39.695313
74
0.221985
0.123993
1
0
0
metastatic
null
null
dnr after sadm
10
52
9.398438
64
16
36.5
null
3.099609
0.599976
0.799927
138
null
294
9
5,525
null
4
adl>=4 (>=5 if sur)
4
312
1
52.91199
male
1
9
ARF/MOSF w/Sepsis
ARF/MOSF
2
12
null
0
101,406
63,986.6562
56,224
34
white
24.699219
34
0.718994
0.632935
30
0
0
yes
0.5
0.2
dnr after sadm
3
151
9.798828
134
30
35.29688
174
null
0.399963
4
132
7.369141
129
50
670
null
3
<2 mo. follow-up
3
9
1
62.86398
male
0
5
CHF
COPD/CHF/Cirrhosis
4
16
$25-$50k
0
null
null
null
7
white
13
13
0.922974
0.869995
1
1
0
no
0.9
0.8
null
null
0
7.199219
0
10
36.09375
115
2.399902
17.699219
1.099854
139
7.399414
51
23
195
1
0
no(M2 and SIP pres)
0
957
0
38.78198
male
0
8
CHF
COPD/CHF/Cirrhosis
1
16
under $11k
0
8,195
5,477.7969
5,594
8.5
white
22.796875
17
0.899902
0.832886
1
0
0
no
0.8
0.7
no dnr
8
153
18.898438
160
40
36.19531
156
null
0.699951
0.5
131
7.429688
78
6
1,945
0
null
null
0.494751
63
1
42.83398
female
0
68
ARF/MOSF w/Sepsis
ARF/MOSF
1
12
null
0
293,248
206,553.625
219,449
42
black
27.398438
44
0.767944
0.69397
28
0
0
no
0.75
0.65
no dnr
68
53
17.5
120
14
38.39844
147.125
2.599609
1
1
135
7.489258
124
16
2,320
null
0
adl>=4 (>=5 if sur)
0
956
0
63.44397
female
1
4
Coma
Coma
1
null
null
100
20,151
13,220.0391
11,825
38
white
30.898438
72
0.070999
0.039993
1
0
0
no
null
null
dnr after sadm
2
70
5.599609
62
20
36.39844
null
null
0.899902
0.899902
138
null
79
11
null
null
null
<2 mo. follow-up
2.631348
4
1
71.10699
female
0
14
COPD
COPD/CHF/Cirrhosis
2
10
under $11k
0
11,445
7,709.0078
8,895
7.333332
white
21.097656
26
0.778931
0.647949
1
0
0
yes
0.6
0.5
dnr after sadm
2
55
39.59375
104
10
36.59375
164
null
1.599854
1.899902
133
7.339844
253
122
618
null
0
no(M2 and SIP pres)
0
79
1
53.73898
female
1
86
MOSF w/Malig
ARF/MOSF
2
16
>$50k
0
264,539
180,809.375
156,199
36.75
white
25.296875
64
0.618896
0.514893
1
0
0
metastatic
0.4
0.2
dnr after sadm
4
119
9.398438
44
42
39.79688
363.3125
null
null
1.099854
143
7.519531
133
17
2,230
null
0
adl>=4 (>=5 if sur)
0
86
1
19.14899
male
0
16
ARF/MOSF w/Sepsis
ARF/MOSF
0
11
$11-$25k
0
43,894
29,063.0938
25,630
13.333328
black
26.199219
32
0.878906
0.836914
5
0
0
no
0.9
0.9
no dnr
16
79
7.599609
92
26
39
null
3
0.599976
2.099609
139
null
99
21
2,425
0
5
no(M2 and SIP pres)
5
953
0
68.31995
male
1
3
ARF/MOSF w/Sepsis
ARF/MOSF
3
12
$11-$25k
0
56,203
35,560.4375
29,180
34
white
46.59375
102
0.166992
0.084
6
0
0
no
null
null
dnr after sadm
3
99
2.5
100
24
36.69531
null
3.799805
0.599976
1.299805
138
null
339
23
null
null
6
<2 mo. follow-up
6
3
1
72.99097
male
1
14
ARF/MOSF w/Sepsis
ARF/MOSF
1
12
null
0
62,598
41,066.875
35,585
19
black
30.796875
49
0.575928
0.465942
1
0
0
yes
0.7
0.6
dnr after sadm
12
75
5.799805
56
16
36.59375
null
4.099609
0.399963
1.299805
138
null
249
48
2,225
null
1
<2 mo. follow-up
1
14
1
72.90295
male
0
8
Lung Cancer
Cancer
2
12
null
0
5,657
3,751.4981
3,824
6.5
white
38.398438
52
0.120987
0.004999
1
1
0
metastatic
1
0.95
no dnr
8
107
14.298828
124
10
35.69531
127.5
3.299805
0.5
2.5
131
7.519531
103
128
3,145
7
6
<2 mo. follow-up
6
36
1
19.96199
female
0
28
ARF/MOSF w/Sepsis
ARF/MOSF
0
12
$25-$50k
0
105,433
71,099.1875
59,291
36.25
black
31.5
53
0.848999
0.796997
1
0
0
no
0.75
0.7
no dnr
28
75
10.898438
72
36
37.89844
228
3.899902
null
1.399902
134
7.289062
105
21
6,710
null
0
no(M2 and SIP pres)
0
951
0
63.74298
female
0
15
CHF
COPD/CHF/Cirrhosis
1
15
$25-$50k
0
50,256
30,249.4531
25,637
18.333328
white
14.898438
27
0.908936
0.845947
1
0
0
no
0.9
0.75
no dnr
15
119
16.597656
66
34
35.29688
376
3.199707
1
0.799927
139
7.449219
199
27
3,485
0
2
no(M2 and SIP pres)
2
950
0
59.48798
male
0
9
Colon Cancer
Cancer
1
12
$11-$25k
0
11,417
7,147.6914
7,076
8
white
16.597656
20
0.832886
0.634888
1
0
0
metastatic
null
null
no dnr
9
70
7.699219
64
18
36.39844
null
3.199707
0.5
1
139
null
113
9
4,000
0
0
SIP>=30
0
149
1
31.797
male
0
51
ARF/MOSF w/Sepsis
ARF/MOSF
1
11
$11-$25k
0
113,949
73,953.375
72,932
31.75
white
26.796875
53
0.86792
0.821899
1
1
0
no
0.6
0.6
dnr after sadm
10
109
3.399902
116
28
36.5
320
3
0.399963
0.899902
129
7.479492
76
13
3,820
null
1
no(M2 and SIP pres)
1
950
0
65.45898
female
0
9
CHF
COPD/CHF/Cirrhosis
2
6
null
0
12,912
9,768.9141
6,986
15
white
20.898438
31
0.850952
0.754883
1
0
0
no
0.99
0.95
no dnr
9
60
15.599609
140
36
35
null
2.199707
18.097656
6.299805
126
null
111
51
80
0
2
<2 mo. follow-up
2
41
1
74.672
male
1
3
MOSF w/Malig
ARF/MOSF
1
8
null
0
48,434
28,172.8281
31,747
44
white
89.6875
96
0
0
16
0
0
yes
null
null
dnr after sadm
3
61
21.296875
104
35
38.5
225
2.299805
28.5
6.899414
131
7.349609
142
110
1,320
null
null
<2 mo. follow-up
1.112793
3
1
58.40698
male
0
5
Lung Cancer
Cancer
1
12
$25-$50k
0
7,980
4,603.7109
3,679
6
white
24.296875
21
0.555908
0.233978
1
0
0
metastatic
null
null
no dnr
5
68
2
106
31
36
172.5
2.099609
22.097656
3.5
136
7.349609
76
117
130
null
null
<2 mo. follow-up
2.232422
11
1
39.34598
male
1
8
ARF/MOSF w/Sepsis
ARF/MOSF
2
12
null
94
37,006
24,103.6406
18,252
32
black
19.898438
33
0.662964
0.565918
3
0
0
no
0.02
0
dnr after sadm
4
59
9.599609
60
32
36.19531
301.625
null
null
2.5
143
7.40918
235
99
1,180
null
0
<2 mo. follow-up
0
8
1
41.90799
female
1
23
MOSF w/Malig
ARF/MOSF
1
13
$11-$25k
0
113,704
73,262.5625
57,339
28.333328
white
24
37
0.619995
0.515991
4
0
0
metastatic
0.2
0.1
dnr after sadm
23
127
8.898438
150
10
39.59375
218
2.899902
1.799805
0.799927
132
7.399414
107
8
630
null
4
<2 mo. follow-up
4
23
1
77.26495
male
1
16
ARF/MOSF w/Sepsis
ARF/MOSF
2
11
null
0
53,824
32,864.5625
28,672
24.333328
white
32.59375
65
0.577881
0.467957
1
1
0
no
0.8
0.8
dnr after sadm
16
111
6.799805
66
24
36.89844
null
null
null
3.699707
141
null
169
26
1,500
null
3
<2 mo. follow-up
3
16
1
65.67798
male
0
16
ARF/MOSF w/Sepsis
ARF/MOSF
4
2
under $11k
0
30,435
20,161.2969
19,058
16.333328
black
30.796875
59
0.618896
0.513916
1
0
0
yes
0.5
0.5
no dnr
16
171
11
116
26
37.69531
393.3125
null
null
1.199951
145
7.599609
144
25
1,565
4
0
no(M2 and SIP pres)
0
230
1
49.29199
female
0
14
ARF/MOSF w/Sepsis
ARF/MOSF
1
9
$25-$50k
0
23,026
14,854.1719
13,023
16.333328
white
26.699219
28
0.726929
0.642944
1
0
0
metastatic
0.3
0.2
no dnr
14
75
10.798828
110
24
36.5
309.5
3.399902
0.5
0.699951
134
7.459961
101
9
1,700
null
1
null
1
221
1
77.17999
female
1
20
ARF/MOSF w/Sepsis
ARF/MOSF
4
8
under $11k
9
32,283
20,509.1406
21,574
15.333328
black
32.398438
53
0.485962
0.367981
4
1
0
no
0.1
0.1
dnr after sadm
6
67
19.898438
124
14
38.89844
250
null
0.5
0.699951
147
7.40918
186
3
4,880
null
4
<2 mo. follow-up
4
20
1
74.52399
male
0
17
ARF/MOSF w/Sepsis
ARF/MOSF
1
12
$11-$25k
0
74,630
46,074.6562
46,423
19.666656
white
29.898438
55
0.564941
0.452942
14
1
0
no
null
null
no dnr
17
129
19.199219
136
12
39.09375
124
1.799805
0.899902
0.399963
140
7.389648
118
11
1,485
null
0
no(M2 and SIP pres)
0
944
0
76.70898
male
1
46
ARF/MOSF w/Sepsis
ARF/MOSF
2
7
under $11k
0
167,401
99,435.5
108,604
33.75
white
25
40
0.746948
0.667969
1
0
0
no
null
null
dnr after sadm
41
69
8.199219
100
12
36.19531
271.375
null
null
0.599976
134
7.449219
146
12
2,600
null
4
<2 mo. follow-up
4
46
1
66.59497
female
1
4
Cirrhosis
COPD/CHF/Cirrhosis
2
14
null
26
5,718
3,435.2969
3,310
16
hispanic
31.796875
66
0.338989
0.151978
1
0
0
no
0
0
dnr after sadm
2
41
21.199219
134
48
35.59375
72
2.299805
10.599609
0.699951
141
7.479492
85
16
1,430
null
7
<2 mo. follow-up
7
4
1
67.02795
male
0
6
COPD
COPD/CHF/Cirrhosis
2
12
$11-$25k
0
13,864
8,040.1992
8,058
22
white
17.097656
35
0.883911
0.805908
1
1
0
no
null
null
no dnr
6
68
10
66
22
36.59375
364
null
null
0.799927
132
7.5
87
7
1,190
0
1
no(M2 and SIP pres)
1
101
1
47.26099
male
0
7
CHF
COPD/CHF/Cirrhosis
2
6
$11-$25k
0
5,337
3,614.2812
3,325
10
black
21.796875
26
0.889893
0.815918
1
0
0
no
null
null
no dnr
7
63
7.599609
100
20
37.09375
null
null
0.399963
1.199951
142
null
51
6
3,200
1
2
no(M2 and SIP pres)
2
266
1
49.69199
male
1
6
Cirrhosis
COPD/CHF/Cirrhosis
1
12
$11-$25k
41
30,257
22,688.4844
17,038
32
white
37.296875
68
0.255981
0.092987
2
0
0
no
0.3
0.3
dnr after sadm
4
30
1.199951
0
10
37.19531
246
null
2.099609
4
137
7.289062
154
99
120
null
0
<2 mo. follow-up
0
6
1
49.5
female
1
15
ARF/MOSF w/Sepsis
ARF/MOSF
2
12
>$50k
0
92,135
57,447.5938
53,565
53.333313
white
42.898438
69
0.397949
0.278992
6
1
0
no
0.6
0.6
dnr after sadm
15
67
4.5
130
28
36.79688
185.6875
3.299805
null
0.699951
143
7.459961
285
25
4,300
null
3
<2 mo. follow-up
3
15
1
72.87598
male
0
7
Lung Cancer
Cancer
3
16
null
0
6,623
4,288.4531
4,394
8.5
white
17.097656
9
0.68689
0.393982
1
0
0
metastatic
0.9
0.6
no dnr
7
135
16.398438
116
28
35.89844
370.3125
null
0.599976
1.299805
137
7.459961
262
29
1,458
0
0
no(M2 and SIP pres)
0
193
1
21.59299
male
0
20
ARF/MOSF w/Sepsis
ARF/MOSF
0
null
null
44
35,222
22,459.4531
20,857
21.333328
white
15.599609
4
0.915894
0.884888
1
0
0
no
0.8
0.7
no dnr
20
63
30.597656
144
25
38.89844
74
2.399902
0.899902
0.799927
130
7.319336
111
20
2,390
null
null
Coma or Intub
1.914551
342
1
65.27295
male
0
11
ARF/MOSF w/Sepsis
ARF/MOSF
2
10
$11-$25k
0
31,903
19,699.6562
20,405
22
white
36.796875
45
0.460999
0.34198
7
0
0
no
0.5
0.4
no dnr
11
118
17.199219
114
34
38.69531
413.3125
3.299805
1
0.599976
136
7.479492
124
6
3,670
0
0
no(M2 and SIP pres)
0
843
1
40.30099
female
0
7
Lung Cancer
Cancer
1
16
$25-$50k
0
5,085
3,449.3496
4,165
9.5
white
33.398438
40
0.356995
0.077988
1
0
0
metastatic
0.8
0.5
no dnr
7
0
23.097656
0
0
39.79688
368
null
3.199707
6.099609
135
7.419922
187
67
0
0
0
no(M2 and SIP pres)
0
291
1
51.09097
male
0
60
ARF/MOSF w/Sepsis
ARF/MOSF
1
14
under $11k
0
167,620
98,773.0625
104,292
28.25
white
33.5
71
0.618896
0.513916
12
0
0
no
null
null
no dnr
60
58
22.097656
95
9
35.89844
163.25
2.199707
1.799805
1.399902
128
7.399414
332
33
8,340
1
2
SIP>=30
2
940
0
31.59499
male
0
10
ARF/MOSF w/Sepsis
ARF/MOSF
1
11
null
0
27,143
16,342.8125
15,221
16.5
black
27.597656
53
0.849976
0.79895
2
0
0
no
null
null
no dnr
10
106
12.5
94
21
36
388.875
null
0.599976
0.899902
137
7.30957
126
22
null
1
0
no(M2 and SIP pres)
0
940
0
39.797
male
0
5
Cirrhosis
COPD/CHF/Cirrhosis
3
14
under $11k
0
5,901
3,753.3652
4,265
12
white
17
23
0.904907
0.839966
1
0
0
no
null
null
no dnr
5
109
28.296875
64
20
37.79688
508.6875
null
null
0.699951
130
7.479492
245
18
null
1
1
no(M2 and SIP pres)
1
940
0
58.33499
male
0
105
ARF/MOSF w/Sepsis
ARF/MOSF
1
9
$11-$25k
0
298,711
201,417.625
23,960
43.5
white
31
40
0.717896
0.631958
1
0
0
no
0.4
0.4
no dnr
105
55
10.398438
110
14
36.09375
170
null
null
0.5
141
7.389648
196
3
2,480
null
5
SIP>=30
5
939
0
59.34598
male
1
6
Coma
Coma
1
0
$11-$25k
94
26,989
19,152.7812
15,365
33
black
18.097656
16
0.418945
0.344971
3
0
0
no
0.01
0
dnr after sadm
5
138
7.599609
84
22
36.29688
null
4.099609
1
1
140
null
83
10
210
null
0
<2 mo. follow-up
0
6
1
52.94199
female
0
14
ARF/MOSF w/Sepsis
ARF/MOSF
2
12
>$50k
0
40,230
24,462.9844
21,977
20.666656
white
17
15
0.888916
0.849976
5
0
0
no
0.7
0.7
no dnr
14
81
100
104
11
36.39844
159.15625
null
null
3.899902
135
7.319336
240
98
1,356
3
0
no(M2 and SIP pres)
0
937
0
44.00497
male
0
19
ARF/MOSF w/Sepsis
ARF/MOSF
0
15
$11-$25k
0
42,924
30,731.9688
28,252
28.666656
white
17.199219
11
0.914917
0.883911
2
0
0
no
0.8
0.8
dnr after sadm
12
62
15.699219
134
30
35.89844
122.5
2.599609
18.699219
1.799805
144
7.5
168
56
790
null
7
Coma or Intub
7
441
1
75.02295
male
0
8
Lung Cancer
Cancer
1
8
under $11k
0
9,280
5,833
5,668
10
white
15.398438
23
0.715942
0.437988
1
0
0
metastatic
null
null
no dnr
8
65
7.5
114
28
38.09375
208.5625
2.599609
1.599854
1.799805
146
7.359375
241
78
2,020
0
0
no(M2 and SIP pres)
0
168
1
60.52798
female
1
38
ARF/MOSF w/Sepsis
ARF/MOSF
5
12
under $11k
0
334,835
253,204
217,423
21.25
white
24.699219
49
0.67395
0.578979
73
1
0
yes
0.2
0.1
dnr after sadm
6
75
12
120
24
37.09375
null
1.5
0.899902
0.799927
136
null
75
21
null
null
0
<2 mo. follow-up
0
38
1
66.93799
male
0
38
ARF/MOSF w/Sepsis
ARF/MOSF
1
12
$25-$50k
0
135,947
75,008
73,737
33
white
36.09375
70
0.406982
0.287964
4
0
0
yes
0.4
0.3
no dnr
38
63
10.398438
104
20
37.59375
336.625
null
0.799927
1.699951
132
7.449219
245
33
880
null
2
adl>=4 (>=5 if sur)
2
934
0
69.70599
male
0
11
CHF
COPD/CHF/Cirrhosis
3
6
$25-$50k
0
23,536
15,357.625
10,738
24
white
27.597656
52
0.718994
0.562988
2
0
0
no
null
null
no dnr
11
119
15.199219
66
36
38.19531
303.3125
null
null
0.899902
133
7.509766
200
7
2,280
1
7
no(M2 and SIP pres)
7
933
0
70.43896
male
0
15
ARF/MOSF w/Sepsis
ARF/MOSF
3
4
null
9
38,926
25,641.9844
21,850
24.333328
white
26.199219
73
0.7229
0.637939
1
0
0
no
0.6
0.5
no dnr
15
79
0.699951
114
45
36.19531
316.625
null
3.5
8.099609
153
7.459961
186
144
3,480
null
null
no(M2 and SIP pres)
2.557617
613
1
92.15594
male
1
3
ARF/MOSF w/Sepsis
ARF/MOSF
1
5
null
0
11,834
6,943.1367
6,614
31
white
57.5
95
0.003
0
2
1
0
no
null
null
dnr after sadm
1
63
12
120
12
36.09375
263.3125
2
2.799805
0.699951
141
7.459961
140
19
2,365
null
0
<2 mo. follow-up
0
3
1
45.59598
female
0
14
ARF/MOSF w/Sepsis
ARF/MOSF
1
11
$11-$25k
0
31,083
20,342.7344
18,127
8.666664
black
17.699219
32
0.903931
0.869995
3
0
0
no
0.85
0.8
no dnr
14
96
7.299805
70
20
36.29688
null
4.099609
1
1.5
136
null
139
31
null
5
0
null
0
933
0
21.85899
male
1
5
ARF/MOSF w/Sepsis
ARF/MOSF
1
null
null
0
159,990
98,132.5
61,458
69
white
38.796875
72
0.635986
0.533936
48
0
0
no
null
null
dnr after sadm
4
65
14.099609
106
20
35.69531
null
3.899902
null
0.899902
128
null
97
14
null
null
null
<2 mo. follow-up
2.019531
5
1
49.69199
female
1
110
ARF/MOSF w/Sepsis
ARF/MOSF
3
9
under $11k
0
536,290
null
null
34.25
black
36.296875
66
0.590942
0.481995
5
1
0
no
0.3
0.2
dnr after sadm
69
78
19.097656
64
9
36.59375
380
2.299805
1.599854
5
129
7.379883
230
99
1,290
null
1
adl>=4 (>=5 if sur)
1
110
1
70.83099
male
0
25
ARF/MOSF w/Sepsis
ARF/MOSF
3
4
under $11k
0
39,684
25,477.6406
31,305
12.5
other
24.398438
33
0.779907
0.708984
1
1
0
no
0.8
0.75
no dnr
25
61
17.699219
106
40
38.59375
177.5
2.099609
0.899902
3.299805
151
7.469727
190
149
173
null
6
adl>=4 (>=5 if sur)
6
270
1
62.54599
male
0
13
MOSF w/Malig
ARF/MOSF
4
14
$25-$50k
0
40,684
25,259.9219
27,094
32.5
white
31.5
47
0.520996
0.404968
1
0
0
yes
0.7
0.5
no dnr
13
73
8.398438
70
28
36.19531
191.40625
null
null
0.5
139
7.389648
80
16
1,100
1
6
adl>=4 (>=5 if sur)
6
189
1
79.95294
male
1
26
ARF/MOSF w/Sepsis
ARF/MOSF
2
null
under $11k
41
101,923
70,486.75
59,330
34.5
black
17.5
36
0.736938
0.655884
1
0
0
no
0.6
0.5
dnr after sadm
23
119
37.296875
176
28
36
223.3125
2.299805
0.299988
0.699951
142
7.5
148
47
1,910
null
null
<2 mo. follow-up
2.765137
26
1
60.20499
male
0
12
ARF/MOSF w/Sepsis
ARF/MOSF
1
7
under $11k
0
36,077
22,552.1875
21,125
34
white
27.699219
55
0.768921
0.694946
1
1
0
no
0.4
0.25
no dnr
12
113
28.097656
106
44
39
240
null
4.5
0.699951
137
7.419922
117
8
4,900
null
1
no(M2 and SIP pres)
1
193
1
58.09998
male
0
13
Lung Cancer
Cancer
2
null
null
0
12,119
7,854.8711
7,984
7.5
white
14.199219
13
0.773926
0.529907
1
0
0
metastatic
0.8
0.4
no dnr
13
27
15.599609
135
12
37.89844
218
1.799805
null
2.399902
135
7.289062
43
48
140
null
null
null
2.822266
108
1
82.37396
female
0
20
ARF/MOSF w/Sepsis
ARF/MOSF
2
7
$11-$25k
0
52,865
36,617.4062
33,561
25.666656
black
30
44
0.573975
0.463989
3
1
0
no
0.5
0.4
no dnr
20
53
17
70
34
38.79688
122
null
0.699951
1.599854
151
7.479492
185
28
2,080
null
0
no(M2 and SIP pres)
0
826
1
70.18799
female
0
15
ARF/MOSF w/Sepsis
ARF/MOSF
0
8
null
9
46,529
31,239.9219
25,634
27
black
17.597656
23
0.851929
0.80188
1
0
0
no
0.25
0.2
no dnr
15
76
4
120
28
38.09375
null
2.199707
0.599976
1.899902
131
null
103
48
1,150
null
0
no(M2 and SIP pres)
0
926
0
66.44995
female
0
19
Coma
Coma
3
null
null
55
28,300
19,586.7188
21,057
13.666664
black
24.199219
52
0.415955
0.342957
1
1
0
no
0.8
0.7
dnr after sadm
1
145
26
144
35
39
84.60938
null
0.399963
0.899902
139
7.439453
94
19
2,595
null
7
null
7
69
1
72.43298
female
0
42
ARF/MOSF w/Sepsis
ARF/MOSF
0
8
under $11k
0
48,857
32,073.5781
38,315
14.25
white
22.199219
28
0.807983
0.743896
1
0
0
no
0.7
0.5
no dnr
42
71
7
64
22
36.59375
291.25
null
null
1.199951
141
7.399414
197
20
1,220
0
null
no(M2 and SIP pres)
0.494751
926
0
40.70398
male
0
71
CHF
COPD/CHF/Cirrhosis
3
12
under $11k
0
207,743
131,070.938
31,629
25.75
black
32
32
0.793945
0.668945
1
0
0
no
null
null
dnr after sadm
39
79
7.599609
116
24
37.79688
null
null
0.399963
1
141
null
103
14
1,925
2
6
adl>=4 (>=5 if sur)
6
99
1
83.76495
male
0
4
CHF
COPD/CHF/Cirrhosis
3
9
$11-$25k
0
5,175
3,558.0781
2,754
17
white
18.796875
29
0.814941
0.699951
1
1
0
no
0.5
0.25
no dnr
4
124
12.298828
136
26
38.39844
142
4.599609
0.199982
1.299805
144
7.419922
474
20
2,155
3
3
adl>=4 (>=5 if sur)
3
99
1
37.80399
male
0
5
Lung Cancer
Cancer
1
null
null
0
5,296
3,480.457
3,060
2
white
10.5
14
0.85498
0.677979
1
0
0
metastatic
0.9
0.5
no dnr
5
122
9.599609
140
28
36.89844
null
null
null
1
140
null
148
5
null
null
null
null
1.781982
182
1
73.57996
male
1
7
MOSF w/Malig
ARF/MOSF
2
14
$11-$25k
0
51,620
33,419.8125
31,452
29.5
white
33.09375
60
0.343994
0.227997
12
1
0
yes
0.9
0.8
dnr after sadm
7
0
1.199951
0
0
38.89844
93.32812
null
1.799805
3.799805
136
7.259766
91
88
1,510
null
null
<2 mo. follow-up
2.959473
7
1